Last reviewed · How we verify
NCT03623880
Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders
NA trial testing Unified Protocol in Pelvic Floor Disorders in 38 participants. Completed in 10 December 2020.
10 December 2020
Quick facts
| Lead sponsor | Northwestern University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 38 |
| Start date | 3 September 2018 |
| Primary completion | 10 December 2020 |
| Estimated completion | 10 December 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Unified Protocol
- Supportive Therapy
Conditions studied
- Pelvic Floor Disorders — all drugs for Pelvic Floor Disorders →
- Anxiety — all drugs for Anxiety →
- Urinary Urgency — all drugs for Urinary Urgency →
- Urinary Incontinence — all drugs for Urinary Incontinence →
Sponsor
Northwestern University
Who can join
18 and older, female only, with Pelvic Floor Disorders or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this proposal is to test a novel behavioral treatment - Unified Protocol Cognitive-Behavior Therapy (UP-CBT)1 - to enhance quality of life in women with pelvic floor disorders. Emotional distress is treatable using behavioral procedures, and effective treatment would increase women's emotional health and help to reduce urinary symptoms (e.g., incontinence, frequent urination). Women with pelvic floor disorders are often seen in the urogynecology clinic, which makes this setting ideal for offering additional interventions that may improve their quality of life. Unfortunately, many women with pelvic floor disorders may not receive effective behavioral treatment, such as cognitive behavior therapy, because urogynecologists and other medical professionals may not be aware of providers in their community who offer this treatment. The investigators will enhance treatment options by 1) providing evidence for an all-purpose cognitive-behavioral intervention (i.e., UP-CBT), 2) offering treatment in the urogynecology clinic, maximizing convenience, and 3) improving clinical outcomes for these patients. Specific Aims: 1. To demonstrate that UP-CBT is an effective form of therapy for women with lower urinary tract symptoms. 2. To use baseline characteristics in moderation analyses to determine which women will be most likely to have a good response to therapy. 3. To use mediation analyses to test a possible causal chain of events - Does treatment lead to lower anxiety, which in turn leads to fewer urinary symptoms?
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Enhancing behavioral treatment for women with pelvic floor disorders: Study protocol for a pilot randomized controlled trial.
Taple BJ, Griffith JW, Weaver C, Kenton KS. · · 2020 · cited 3× · PMID 31956723 · DOI 10.1016/j.conctc.2019.100514
Verify or expand the search:
- PubMed search for NCT03623880
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Unified Protocol
Trials testing the same drug.
- NCT07070531 — Unified Protocol in Penitentiary Facilities · NA · not yet recruiting
- NCT06906991 — Multicomponent FIBROWALK Therapy Plus Unified Protocol for Emotional Regulation in Individuals With Fibromyalgia · NA · not yet recruiting
- NCT06384196 — Identity-Based Transdiagnostic Therapy for Young People With Anxiety and Depression · NA · recruiting
- NCT06722781 — Trial of an Online Group Psychotherapy Intervention for Common Mental Health Disorders · NA · recruiting
- NCT06777693 — The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Older Adults: a Feasibility Study · NA · enrolling by invitation
Other recruiting trials for Pelvic Floor Disorders
Currently open trials in the same condition.
- NCT07268014 — Effects of Pelvic Exercises on Birth and Incontinence · NA · recruiting
- NCT06986824 — Perineal Massage Using A Pelvic Wand During Pregnancy · Phase 4 · recruiting
- NCT07004738 — Assessment of Rectus Abdominis Muscle Thickness and Residual Bladder Volume Before and After Pelvic Floor Exercises · NA · active not recruiting
- NCT06796985 — Botox for Chronic Pelvic Pain · Phase 1 · recruiting
- NCT06808542 — Pelvic Floor Dysfunction Among Female Physiotherapy Students: A Cross-Sectional Study · recruiting
Other Northwestern University trials
Trials by the same sponsor.
- NCT06545695 — Epidermal Growth Factor Receptor Inhibition for Keratinopathies · Phase 1, PHASE2 · not yet recruiting
- NCT07261657 — N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C · EARLY_PHASE1 · not yet recruiting
- NCT07392775 — ALDH2 Genetic Testing in East Asian Community · NA · not yet recruiting
- NCT06886776 — Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Ill · NA · not yet recruiting
- NCT07469176 — Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03623880 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northwestern University
- Last refreshed: 30 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03623880.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing